Citations (67)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (7)
Karima Alim, Arnaud Bruyère, Alain Lescoat, Elodie Jouan, Valérie Lecureur, Marc Le Vée & Olivier Fardel. (2021) Interactions of janus kinase inhibitors with drug transporters and consequences for pharmacokinetics and toxicity. Expert Opinion on Drug Metabolism & Toxicology 17:3, pages 259-271.
Read now
Read now
Eva Ramboer, Tamara Vanhaecke, Vera Rogiers & Mathieu Vinken. (2013) Primary hepatocyte cultures as prominent in vitro tools to study hepatic drug transporters. Drug Metabolism Reviews 45:2, pages 196-217.
Read now
Read now
Olivier Fardel. (2013) Cytokines as molecular targets for aryl hydrocarbon receptor ligands: implications for toxicity and xenobiotic detoxification. Expert Opinion on Drug Metabolism & Toxicology 9:2, pages 141-152.
Read now
Read now
Tommy B Andersson, Kajsa P Kanebratt & John Gerry Kenna. (2012) The HepaRG cell line: a unique in vitro tool for understanding drug metabolism and toxicology in human. Expert Opinion on Drug Metabolism & Toxicology 8:7, pages 909-920.
Read now
Read now
Alexander M Cressman, Vanja Petrovic & Micheline Piquette-Miller. (2012) Inflammation-mediated changes in drug transporter expression/activity: implications for therapeutic drug response. Expert Review of Clinical Pharmacology 5:1, pages 69-89.
Read now
Read now
Olivier Fardel, Elise Kolasa & Marc Le Vee. (2012) Environmental chemicals as substrates, inhibitors or inducers of drug transporters: implication for toxicokinetics, toxicity and pharmacokinetics. Expert Opinion on Drug Metabolism & Toxicology 8:1, pages 29-46.
Read now
Read now
Neill James Liptrott & Andrew Owen. (2011) The role of cytokines in the regulation of drug disposition: extended functional pleiotropism?. Expert Opinion on Drug Metabolism & Toxicology 7:3, pages 341-352.
Read now
Read now
Articles from other publishers (60)
Valentin Tastet, Marc Le Vée, Marie Kerhoas, Anna Zerdoug, Elodie Jouan, Arnaud Bruyère & Olivier Fardel. (2023) Interactions of organophosphate flame retardants with human drug transporters. Ecotoxicology and Environmental Safety 263, pages 115348.
Crossref
Crossref
Mahir Bhardwaj, Abhishek Gour, Ajaz Ahmed, Sumit Dhiman, Diksha Manhas, Parul Khajuria, Priya Wazir, Debaraj Mukherjee & Utpal Nandi. (2023) Impact of Disease States on the Oral Pharmacokinetics of EIDD-1931 (an Active Form of Molnupiravir) in Rats for Implication in the Dose Adjustment. Molecular Pharmaceutics.
Crossref
Crossref
Leandro Francisco Pippa, Carolina Pinto Vieira, Juciene Aparecida Caris, Adriana Rocha, Maria Paula Marques, Camile Prates Garcia, Rosamar Eulira Fontes Rezende & Vera Lucia Lanchote. (2023) Effect of Chronic Hepatitis C on the Activity of the Membrane Transporters P‐gp and OATP1B1/BCRP on Patients With Different Stages of Hepatic Fibrosis. Clinical Pharmacology & Therapeutics 114:1, pages 173-181.
Crossref
Crossref
Takashi Ashino, Yuki Nakamura, Hirokazu Ohtaki, Yoichiro Iwakura & Satoshi Numazawa. (2023) Interleukin-6 regulates the expression of hepatic canalicular efflux drug transporters after cecal ligation and puncture-induced sepsis: A comparison with lipopolysaccharide treatment. Toxicology Letters 374, pages 40-47.
Crossref
Crossref
Kuan-Fu Chen, Hannah M. Jones & Katherine L. Gill. (2022) Physiologically Based Pharmacokinetic Modeling To Predict Drug-Biologic Interactions with Cytokine Modulators: Are These Relevant and Is Interleukin-6 Enough?. Drug Metabolism and Disposition 50:10, pages 1322-1331.
Crossref
Crossref
Anna Zerdoug, Marc Le Vée, Shotaro Uehara, Béatrice Lopez, Christophe Chesné, Hiroshi Suemizu & Olivier Fardel. (2022) Contribution of Humanized Liver Chimeric Mice to the Study of Human Hepatic Drug Transporters: State of the Art and Perspectives. European Journal of Drug Metabolism and Pharmacokinetics 47:5, pages 621-637.
Crossref
Crossref
Marek Droździk, Joanna Lapczuk-Romanska, Christoph Wenzel, Łukasz Skalski, Sylwia Szeląg-Pieniek, Mariola Post, Marta Syczewska, Mateusz Kurzawski & Stefan Oswald. (2022) Protein Abundance of Drug Transporters in Human Hepatitis C Livers. International Journal of Molecular Sciences 23:14, pages 7947.
Crossref
Crossref
Sonia Saib, Sophie Hodin, Clément Mercier, Mireille Paul, Valérie Bin, Edouard Ollier & Xavier Delavenne. (2022)
TNF-α and IL-1β Exposure Modulates the Expression and Functionality of
P
-Glycoprotein in Intestinal and Renal Barriers
. Molecular Pharmaceutics 19:7, pages 2327-2334.
Crossref
Crossref
Leandro Francisco Pippa, Carolina Pinto Vieira, Juciene Aparecida Caris, Adriana Rocha, Camile Prates Garcia, Rosamar Eulira Fontes Rezende & Vera Lucia Lanchote. (2021) Clinical treatment for hepatitis C reverses CYP2C19 inhibition. British Journal of Clinical Pharmacology 87:10, pages 4013-4019.
Crossref
Crossref
Sonia Saib & Xavier Delavenne. (2021) Inflammation Induces Changes in the Functional Expression of P-gp, BCRP, and MRP2: An Overview of Different Models and Consequences for Drug Disposition. Pharmaceutics 13:10, pages 1544.
Crossref
Crossref
Sara De Martin, Emanuela Bonaiuto & Daniela Gabbia. 2021. Diseases of the Liver and Biliary Tree. Diseases of the Liver and Biliary Tree
211
227
.
Sheena Sharma, Deepak Suresh Ahire & Bhagwat Prasad. (2020) Utility of Quantitative Proteomics for Enhancing the Predictive Ability of Physiologically Based Pharmacokinetic Models Across Disease States. The Journal of Clinical Pharmacology 60:S1.
Crossref
Crossref
Marc Le Vée, Arnaud Bruyère, Elodie Jouan & Olivier Fardel. (2020) Janus kinase-dependent regulation of drug detoxifying protein expression by interleukin-22 in human hepatic cells. International Immunopharmacology 83, pages 106439.
Crossref
Crossref
Juciene Aparecida Caris, Jhohann Richard de Lima Benzi, Flávio Falcão Lima de Souza, Renê Donizeti Ribeiro de Oliveira, Eduardo Antônio Donadi & Vera Lucia Lanchote. (2020) Rheumatoid arthritis downregulates the drug transporter OATP1B1: Fluvastatin as a probe. European Journal of Pharmaceutical Sciences 146, pages 105264.
Crossref
Crossref
Navaz Karimian Pour & Micheline Piquette-Miller. (2020) Dysregulation of renal transporters in a rodent model of viral Infection. International Immunopharmacology 80, pages 106135.
Crossref
Crossref
Nelly Guéniche, Arnaud Bruyere, Marc Le Vée & Olivier Fardel. (2019) Implication of human drug transporters to toxicokinetics and toxicity of pesticides. Pest Management Science 76:1, pages 18-25.
Crossref
Crossref
Navaz Karimian Pour, Eliza R. McColl & Micheline Piquette-Miller. (2019) Impact of Viral Inflammation on the Expression of Renal Drug Transporters in Pregnant Rats. Pharmaceutics 11:12, pages 624.
Crossref
Crossref
Christian Richter, Ovidiu C. Andronesi, Ronald J.H. Borra, Felix Voigt, Steffen Löck, Dan G. Duda, Alexander R. Guimaraes, Theodore S. Hong, Thomas R. Bortfeld & Joao Seco. (2019) Inter-patient variations of radiation-induced normal-tissue changes in Gd-EOB-DTPA-enhanced hepatic MRI scans during fractionated proton therapy. Clinical and Translational Radiation Oncology 18, pages 113-119.
Crossref
Crossref
Ahmad Sharanek, Audrey Burban, Nadia Ciriaci & André Guillouzo. (2019) Pro-inflammatory cytokines enhance dilatation of bile canaliculi caused by cholestatic antibiotics. Toxicology in Vitro 58, pages 51-59.
Crossref
Crossref
Tomomi Yamada, Yuto Kashiwagi, Takemi Rokugawa, Hideaki Kato, Haruyo Konishi, Tadateru Hamada, Ryohei Nagai, Yusaku Masago, Michiko Itoh, Takayoshi Suganami, Yoshihiro Ogawa & Kohji Abe. (2019) Evaluation of hepatic function using dynamic contrast-enhanced magnetic resonance imaging in melanocortin 4 receptor-deficient mice as a model of nonalcoholic steatohepatitis. Magnetic Resonance Imaging 57, pages 210-217.
Crossref
Crossref
Olivier Fardel, Amélie Moreau, Marc Le Vée, Claire Denizot & Yannick Parmentier. (2018) Evaluation of Drug Biliary Excretion Using Sandwich-Cultured Human Hepatocytes. European Journal of Drug Metabolism and Pharmacokinetics 44:1, pages 13-30.
Crossref
Crossref
Abdullah Mayati, Amélie Moreau, Elodie Jouan, Marie Febvre-James, Claire Denizot, Yannick Parmentier & Olivier Fardel. (2018) mRNA Expression and Activity of Nucleoside Transporters in Human Hepatoma HepaRG Cells. Pharmaceutics 10:4, pages 246.
Crossref
Crossref
Raymond Evers, Micheline Piquette‐Miller, Joseph W. Polli, Frans G.M. Russel, Jason A. Sprowl, Kimio Tohyama, Joseph A. Ware, Saskia N. de Wildt, Wen Xie & Kim L.R. Brouwer. (2018) Disease‐Associated Changes in Drug Transporters May Impact the Pharmacokinetics and/or Toxicity of Drugs: A White Paper From the International Transporter Consortium. Clinical Pharmacology & Therapeutics 104:5, pages 900-915.
Crossref
Crossref
Alexander Batista-Duharte, Damiana Téllez Martínez & Iracilda Zeppone Carlos. (2018) Efficacy and safety of immunological adjuvants. Where is the cut-off?. Biomedicine & Pharmacotherapy 105, pages 616-624.
Crossref
Crossref
Mi Jang, Andreas Manz, Thomas Volk & Astrid Kleber. (2018) Study of melatonin-mediated effects on various hepatic inflammatory responses stimulated by IL-6 in a new HepG2-on-a-chip platform. Biomedical Microdevices 20:3.
Crossref
Crossref
Marie Febvre-James, Arnaud Bruyère, Marc Le Vée & Olivier Fardel. (2018) The JAK1/2 Inhibitor Ruxolitinib Reverses Interleukin-6-Mediated Suppression of Drug-Detoxifying Proteins in Cultured Human Hepatocytes. Drug Metabolism and Disposition 46:2, pages 131-140.
Crossref
Crossref
Kerry B. Goralski, Matthew A. Ladda & Jenna O. McNeil. 2018. Drug Interactions in Infectious Diseases: Mechanisms and Models of Drug Interactions. Drug Interactions in Infectious Diseases: Mechanisms and Models of Drug Interactions
163
204
.
Alexander V. LyubimovEugenia Kraynov & Steven W. Martin. 2011. Encyclopedia of Drug Metabolism and Interactions. Encyclopedia of Drug Metabolism and Interactions
1
22
.
Niresh Hariparsad, Diane Ramsden, Jairam Palamanda, Joshua G. Dekeyser, Odette A. Fahmi, Jane R. Kenny, Heidi Einolf, Michael Mohutsky, Magalie Pardon, Y. Amy Siu, Liangfu Chen, Michael Sinz, Barry Jones, Robert Walsky, Shannon Dallas, Suresh K. Balani, George Zhang, David Buckley & Donald Tweedie. (2017) Considerations from the IQ Induction Working Group in Response to Drug-Drug Interaction Guidance from Regulatory Agencies: Focus on Downregulation, CYP2C Induction, and CYP2B6 Positive Control. Drug Metabolism and Disposition 45:10, pages 1049-1059.
Crossref
Crossref
Abdullah Mayati, Amélie Moreau, Claire Denizot, Bruno Stieger, Yannick Parmentier & Olivier Fardel. (2017) β2-adrenergic receptor-mediated in vitro regulation of human hepatic drug transporter expression by epinephrine. European Journal of Pharmaceutical Sciences 106, pages 302-312.
Crossref
Crossref
Yanling Zhao, Xuan He, Xiao Ma, Jianxia Wen, Pengyan Li, Jiabo Wang, Ruisheng Li, Yun Zhu, Shizhang Wei, Haotian Li, Xuelin Zhou, Kun Li, Honghong Liu & Xiaohe Xiao. (2017) Paeoniflorin ameliorates cholestasis via regulating hepatic transporters and suppressing inflammation in ANIT-fed rats. Biomedicine & Pharmacotherapy 89, pages 61-68.
Crossref
Crossref
D. Kojovic & M. Piquette-Miller. 2017. Drug Metabolism in Diseases. Drug Metabolism in Diseases
59
89
.
Elodie Jouan, Marc Le Vée, Claire Denizot, Yannick Parmentier & Olivier Fardel. (2016) Drug Transporter Expression and Activity in Human Hepatoma HuH-7 Cells. Pharmaceutics 9:4, pages 3.
Crossref
Crossref
Mitesh Patel, Kunal S. Taskar & Maciej J. Zamek-Gliszczynski. (2016) Importance of Hepatic Transporters in Clinical Disposition of Drugs and Their Metabolites. The Journal of Clinical Pharmacology 56, pages S23-S39.
Crossref
Crossref
Marc Le Vee, Elodie Jouan, Gregory Noel, Bruno Stieger & Olivier Fardel. (2015) Polarized location of SLC and ABC drug transporters in monolayer-cultured human hepatocytes. Toxicology in Vitro 29:5, pages 938-946.
Crossref
Crossref
Theresa V. Nguyen, Okechukwu Ukairo, Salman R. Khetani, Michael McVay, Chitra Kanchagar, Wolfgang Seghezzi, Gulesi Ayanoglu, Onyi Irrechukwu & Raymond Evers. (2015) Establishment of a Hepatocyte-Kupffer Cell Coculture Model for Assessment of Proinflammatory Cytokine Effects on Metabolizing Enzymes and Drug Transporters. Drug Metabolism and Disposition 43:5, pages 774-785.
Crossref
Crossref
Marc Le Vee, Elodie Jouan, Bruno Stieger, Valérie Lecureur & Olivier Fardel. (2015) Regulation of Human Hepatic Drug Transporter Activity and Expression by Diesel Exhaust Particle Extract. PLOS ONE 10:3, pages e0121232.
Crossref
Crossref
Rashmi R. Shah & Robert L. Smith. (2015) Inflammation-Induced Phenoconversion of Polymorphic Drug Metabolizing Enzymes: Hypothesis with Implications for Personalized Medicine. Drug Metabolism and Disposition 43:3, pages 400-410.
Crossref
Crossref
Aiko Iida, Shohei Ouchi, Toshio Oda, Jun Aketagawa, Yasuhiko Ito, Yusuke Takizawa, Mikio Tomita & Masahiro Hayashi. (2014) RETRACTED ARTICLE: Changes of Absorptive and Secretory Transporting System of (1 → 3) β-D-glucan Based on Efflux Transporter in Indomethacin-induced Rat. European Journal of Drug Metabolism and Pharmacokinetics 40:1, pages 29-38.
Crossref
Crossref
Christian Richter, Joao Seco, Ted S. Hong, Dan G. Duda & Thomas Bortfeld. (2014) Radiation-induced changes in hepatocyte-specific Gd-EOB-DTPA enhanced MRI: Potential mechanism. Medical Hypotheses 83:4, pages 477-481.
Crossref
Crossref
Brian C. Ferslew, Kathleen Köck & Kim L. R. Brouwer. 2014. Drug Transporters. Drug Transporters
245
271
.
Mohammad K. Miah, Imam H. Shaik, Ulrich Bickel & Reza Mehvar. (2013) Effects of Hepatic Ischemia-Reperfusion Injury on the P-Glycoprotein Activity at the Liver Canalicular Membrane and Blood–Brain Barrier Determined by In Vivo Administration of Rhodamine 123 in Rats. Pharmaceutical Research 31:4, pages 861-873.
Crossref
Crossref
Pradeep B. Lukka, Ying Yi Chen, Graeme J. Finlay, Wayne R. Joseph, Emma Richardson, James W. Paxton & Bruce C. Baguley. (2013) Tumour tissue selectivity in the uptake and retention of SN 28049, a new topoisomerase II-directed anticancer agent. Cancer Chemotherapy and Pharmacology 72:5, pages 1013-1022.
Crossref
Crossref
Raymond Evers, Shannon Dallas, Leslie J. Dickmann, Odette A. Fahmi, Jane R. Kenny, Eugenia Kraynov, Theresa Nguyen, Aarti H. Patel, J. Greg Slatter & Lei Zhang. (2013) Critical Review of Preclinical Approaches to Investigate Cytochrome P450–Mediated Therapeutic Protein Drug-Drug Interactions and Recommendations for Best Practices: A White Paper. Drug Metabolism and Disposition 41:9, pages 1598-1609.
Crossref
Crossref
Marc Le Vee, Gregory Noel, Elodie Jouan, Bruno Stieger & Olivier Fardel. (2013) Polarized expression of drug transporters in differentiated human hepatoma HepaRG cells. Toxicology in Vitro 27:6, pages 1979-1986.
Crossref
Crossref
Theresa Nguyen, Narendra Kishnani & Raymond Evers. 2010. Pharmaceutical Sciences Encyclopedia. Pharmaceutical Sciences Encyclopedia
1
30
.
Sibylle Neuhoff & Geoff T. Tucker. (2013) Comment on the Article ?Physiologically Based Modeling of Pravastatin Transporter-Mediated Hepatobiliary Disposition and Drug-Drug Interactions?. Pharmaceutical Research 30:6, pages 1467-1468.
Crossref
Crossref
Lea Saab, Jean Peluso, Christian D. Muller & Genevieve Ubeaud-Sequier. (2013) Implication of hepatic transporters (MDR1 and MRP2) in inflammation-associated idiosyncratic drug-induced hepatotoxicity investigated by microvolume cytometry. Cytometry Part A 83A:4, pages 403-408.
Crossref
Crossref
Marc Le Vee, Elodie Jouan, Bruno Stieger & Olivier Fardel. (2013) Differential regulation of drug transporter expression by all-trans retinoic acid in hepatoma HepaRG cells and human hepatocytes. European Journal of Pharmaceutical Sciences 48:4-5, pages 767-774.
Crossref
Crossref
Dirk Theile, Walter Emil Haefeli, Helmut Karl Seitz, Gunda Millonig, Johanna Weiss & Sebastian Mueller. (2013) Association of Liver Stiffness with Hepatic Expression of Pharmacokinetically Important Genes in Alcoholic Liver Disease. Alcoholism: Clinical and Experimental Research 37, pages E17-E22.
Crossref
Crossref
Alexander V. LyubimovEdward T. Morgan, Choon‐Myung Lee & Beatrice A. Nyagode. 2011. Encyclopedia of Drug Metabolism and Interactions. Encyclopedia of Drug Metabolism and Interactions
1
45
.
Kewei Wang & Ai-Xuan Holterman. (2012) Pathophysiologic role of hepatocyte nuclear factor 6. Cellular Signalling 24:1, pages 9-16.
Crossref
Crossref
Am?lie Moreau, Marc Le Vee, Elodie Jouan, Yannick Parmentier & Olivier Fardel. (2011) Drug transporter expression in human macrophages. Fundamental & Clinical Pharmacology 25:6, pages 743-752.
Crossref
Crossref
S. Lee, A. Childerhouse & K. Moss. (2011) Gastrointestinal symptoms and granulomatous vasculitis involving the liver in giant cell arteritis: a case report and review of the literature. Rheumatology 50:12, pages 2316-2317.
Crossref
Crossref
Marc Le Vee, Elodie Jouan, Bruno Stieger, Valérie Lecureur & Olivier Fardel. (2011) Regulation of drug transporter expression by oncostatin M in human hepatocytes. Biochemical Pharmacology 82:3, pages 304-311.
Crossref
Crossref
Manmeet S. Padda, Mayra Sanchez, Abbasi J. Akhtar & James L. Boyer. (2011) Drug-induced cholestasis. Hepatology 53:4, pages 1377-1387.
Crossref
Crossref
Marc Le Vee, Elodie Jouan, Amélie Moreau & Olivier Fardel. (2011) Regulation of drug transporter mRNA expression by interferon-γ in primary human hepatocytes. Fundamental & Clinical Pharmacology 25:1, pages 99-103.
Crossref
Crossref
Jenna O. McNeil & Kerry B. Goralski. 2011. Drug Interactions in Infectious Diseases. Drug Interactions in Infectious Diseases
167
201
.
Lei Diao, Na Li, Timothy G. Brayman, Kathy J. Hotz & Yurong Lai. (2010) Regulation of MRP2/ABCC2 and BSEP/ABCB11 Expression in Sandwich Cultured Human and Rat Hepatocytes Exposed to Inflammatory Cytokines TNF-α, IL-6, and IL-1β. Journal of Biological Chemistry 285:41, pages 31185-31192.
Crossref
Crossref
K. Sandy Pang, Raimund M. Peter & A. David Rodrigues. 2010. Enzyme- and Transporter-Based Drug-Drug Interactions. Enzyme- and Transporter-Based Drug-Drug Interactions
701
722
.